Astrazeneca shares last traded at $156.3930, with a volume of 2,482,363 shares. Astrazeneca News SummaryHere are the key news stories impacting Astrazeneca this week:Get Astrazeneca alerts:Analysts Set New Price TargetsA number of analysts recently weighed in on AZN shares. UBS Group reaffirmed a “buy” rating on shares of Astrazeneca in a report on Friday, April 10th. The Goldman Sachs Group reiterated a “buy” rating on shares of Astrazeneca in a research report on Wednesday, July 1st. Finally, Jefferies Financial Group restated a “buy” rating on shares of Astrazeneca in a research report on Friday, June 26th.